Ingudi

Names and identification

Language	Name
English	Ingudi
Latin/Botanical	Balanites aegyptiaca (L.) Delile

Key Phytochemical Constituents

• Diosgenin (steroidal sapogenin)
• Yamogenin
• Balanitin-6
• Balanitin-7
• Furostanol saponins (24 types identified)
• Phenolic acids
• Flavonoids (14 identified)
• Coumarins
• Beta-sitosterol
• Polysterols
• Linoleic acid (seed oil, ~54% unsaturated)

How does it work?

• Anticancer activity via steroidal saponin (balanitin)-mediated induction of apoptosis and cell cycle arrest in tumor cells
• Antidiabetic action through diosgenin-mediated enhancement of insulin sensitivity and beta-cell protection
• Molluscicidal activity through saponin-mediated disruption of snail cell membranes (bilharzia/schistosomiasis vector control)
• Anti-inflammatory effects via phenolic acid and flavonoid-mediated inhibition of pro-inflammatory mediators

Which traditional uses are supported by research?

• Anthelmintic and antiparasitic use validated through molluscicidal and antischistosomal studies
• Wound healing validated through antimicrobial and tissue repair promotion studies
• Laxative use confirmed through preclinical motility studies
• Skin disease treatment (leprosy, leukoderma) supported by antimicrobial and anti-inflammatory preclinical evidence

What do recent clinical trials show?

• Ibrahim OHM, Al-Qurashi AD, Asiry KA and others 2022. Investigation of Potential In Vitro Anticancer and Antimicrobial Activities of Balanites aegyptiaca (L.) Delile Fruit Extract and Its Phytochemical Components. Plants (Basel, Switzerland). PMID 36235487 · doi:10.3390/plants11192621
  Fruit extract demonstrated significant antiproliferative activity against lung, liver and brain carcinoma cell lines with concurrent antimicrobial effects against clinical isolates.

2 further claims previously listed here could not be traced to a published paper and have been removed. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

• Toxicological studies have confirmed safety for medicinal purposes at recommended doses; fruit mesocarp is traditionally consumed as food
• Saponin-rich kernel preparations should be used cautiously as high saponin concentrations may cause hemolysis; seed kernel detoxification processing required before consumption

What is it made of?

Key Active Markers

• Diosgenin
• Yamogenin
• Saponins
• Flavonoids
• Coumarins
• Sitosterol
• Balanitin-6
• Balanitin-7
• Furostanol
• Phenolic acids

Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)

Dosage forms and preparation

Dosage Forms: Taila (oil), Churna (seed powder), Lepa (external paste), Capsule

Standard Dosage: 3-5g seed kernel powder; 5-10ml oil for external application; 1-3g purified seed powder internally

Bioavailability: Balanites aegyptiaca (desert date) contains saponins (diosgenin-type), fixed oils, and flavonoids. Diosgenin has moderate oral bioavailability (~15-20%); co-administration with lipids enhances absorption. Saponin glycosides are hydrolyzed by gut bacteria to absorbable aglycones. Oil fraction is well absorbed.

Optimal Timing: External oil application morning and evening; internal use under physician guidance only, before meals

Standardized Extract: Cold-pressed seed oil; Shodhita (purified) seed extract with controlled saponin content

Shelf Life: 1 year (cold-pressed oil); 2 years (powder); 3 years (capsule)

Storage: Oil: cool place, away from light, in dark glass bottles. Powder: airtight container below 25°C.

Marker Compounds: Diosgenin, Yamogenin, Balanitin, Beta-sitosterol, Stigmasterol

Extraction Methods

• Cold pressing (seed oil)
• Hydroalcoholic extraction (60:40) for saponin fraction
• Aqueous extraction for water-soluble components
• Shodhana processing with cow’s milk before internal use

Synergistic Combinations

• With Eranda Taila for joint pain (external)
• With Guggulu for anti-inflammatory action
• With Nimba for skin conditions